...in the capital markets to attract financing. The Office of Technology Assessment ("OTA") explained, Pharmaceutical R&D is an investment, and the principal...careful consideration of the effects on R&D is needed." It is fair to ask why pension funds, institutions and other investors would assume more risk by investing...

...in the capital markets to attract financing. The Office of Technology Assessment ("OTA") explained, Pharmaceutical R&D is an investment, and the principal...changes, careful consideration of the effects on R&D is needed.1 It is fair to ask why pension funds, institutions and other investors would assume more risk...

...editorial in the April 2, 1993 issue of Science states. Drug development is both expensive and risky. "Pharmaceutical R&D is a risky investment; therefore,...companies to invest in researching new chemical entities,' the Office of Technology Assessment stated In a 1993 report. "Specific policies of US and other governments...

...development." •Pharmaceutical R6D Is a risky investment,' the OTA stated In Its February 1993 report. "Therefore, high financial returns are necessary to...Induce companies to Invest In researching new chemical entitles." The OTA study focuses In large part on drugs approved by FDA In the early 1960s, and on...

...PUBLICATIONS PRINTED AND DELIVERED IN FISCAL YEAR 1993 Pharmaceutical R&D: Costs, Risks, and Rewards Pharmaceutical costs are among the fastest growing...careful consideration of the effects on R&D is needed. Drug Labeling in Developing Countries This report evaluates the prescribing information — "labeling"...

...PUBLICATIONS PRINTED AND DELIVERED IN FISCAL YEAR 1993 Pharmaceutical R&D: Costs, Risks, and Rewards Pharmaceutical costs are among the fastest growing...careful consideration of the effects on R&D is needed. Drug Labeling in Developing Countries This report evaluates the prescribing information — "labeling"...

...health of Americans, for health care costs, and for the future of the US pharmaceutical industry. OTA's report focuses mainly on the economic side of the...careful consideration of the effects on R&D is needed. The specific request for this study came from the House Committee on Energy and Commerce and its Subcommittee...

...investment, and the principal characteristic of an investment is that money is spent today in the hopes or generating even more money in the future. Pharmaceutical...changes, careful consideration of the effects on R&D is needed.8 It is fair to ask why pension funds, institutions and other investors would assume more risk...

...development." •Pharmaceutical R&D is a risky investment,* the OTA stated in its February 1993 report. "Therefore, high financial returns are necessary to...companies to invest in researching new chemical entities." The OTA study focuses in large part on drugs approved by FDA in the early 1960s, and on market conditions...

...HIV prevention by the CDC. Fiscal Year 1993 Pharmaceutical R&D: Costs, Risks, and Rewards $312,847 Pharmaceutical costs are among the fastest growing...careful consideration of the effects on R&D is needed. Requested by: House Committee on Energy and Commerce Hon. John D. Dingell, Chairman Hon. Henry A. Waxman,...